[Exclusive]Reproductive Company Incinta Lands A Few Million Dollars in Series A Financing

In recent days, a reproductive health company named Incinta received a few million dollars in Series A financing. This round of financing was led by Alpha Dollar Fund, and Haoyue Capital serves as the company's financial advisor.

Founded in 2014, Incinta has been focused on investment and management in the field of assisted reproductive medicine at home and abroad. Currently, Incinta's medical institutions are located in China, Southeast Asia and North America.

The funds from this round of financing will be used to expand Incinta's medical institutions in China and around the world to further meet the needs of patients. Incinta's new reproductive health center in North America will open in the second half of the year. This base is the best reproductive health and R&D center in North America with the best conditions, technology and service.

According to Frost & Sullivan's report, in 2017, there were approximately 47.7 million infertile couples in China, of which only about 527,000 couples received reproductive health services. Domestic reproductive services will continue to be a great market in the future. Based on this positioning, Incinta has grown rapidly in the few years and has developed in-depth cooperation with community hospitals for mutual benefit.

Founded in 2013, Haoyue Capital is an investment bank focusing on providing financial services to Chinese healthcare companies.